Ise
Hiroyoshi Ise, Bear, DE US
Patent application number | Description | Published |
---|---|---|
20130253563 | Dilator Centering Device And Assemblies - The present technology is directed to a dilator centering device and assemblies and methods using same. In particular, a dilator centering device in accordance with the disclosed technology can be used with a sheath hub assembly. In one embodiment, a dilator centering device includes a lumen capable of receiving a dilator shaft and centering a dilator shaft with respect to the sheath hub as the dilator shaft enters the sheath hub. In one embodiment, the dilator centering device can be attached to the sheath hub during manufacturing or it can be attached at the use site. In one embodiment, the dilator centering device can be integrated with and non-removable from the sheath hub. The embodiments disclosed herein are illustrative and do not limit the scope and spirit of the disclosed technology. | 09-26-2013 |
Hiroyoshi Ise, Elkton, MD US
Patent application number | Description | Published |
---|---|---|
20130150807 | STRAIN RELIEF AND CATHETER WITH STRAIN RELIEF - Disclosed herein is a strain relief having a plurality of enclosing parts arranged in an axial direction and enclosing a longitudinal axis of the strain relief. A space portion can be formed between adjacent enclosing parts so that the strain relief is freely bendable. In the strain relief, the adjacent enclosing parts are interconnected, and one or both of opposed surfaces of the adjacent enclosing parts can be provided with a projection that projects in a direction substantially parallel with the longitudinal axis. | 06-13-2013 |
Martin Ise, Erlangen DE
Patent application number | Description | Published |
---|---|---|
20130112569 | ENERGY STORAGE DEVICE AND METHOD FOR THE REVERSIBLE STORAGE OF ENERGY - An energy storage device for a reversible storage of energy has a reversibly designed metal/metal oxide storage unit for indirectly storing energy in form of a fluid material and a reversibly designed electrolysis device for providing and using the fluid material in an electrolysis reaction. The metal/metal oxide storage unit is disposed spatially separated from the electrolysis device. A fluid exchanging unit is provided for exchanging the fluid material between the reversibly designed metal/metal oxide storage unit and the electrolysis device, and a heat exchanging unit is provided for exchanging thermal energy between the metal/metal oxide storage unit and the electrolysis device. Further, a method for a reversible storage of energy is provided. | 05-09-2013 |
20130126360 | METHOD FOR PRODUCING HYDROGEN FROM WATER BY MEANS OF A HIGH-TEMPERATURE ELECTROLYZER - Water is heated to a process temperature of an electrolyzer, e.g., more than 500° C. Then, the water is electrolyzed in the electrolyzer to form product gases hydrogen (H | 05-23-2013 |
Toshihiro Ise US
Patent application number | Description | Published |
---|---|---|
20130207540 | Organic Electroluminescent Element - Disclosed is an organic electroluminescent element which has high luminous efficiency, a low driving voltage, high durability in a high-current-density region, and little change in chromaticity before and after the driving in a high-current-density region. Specifically disclosed is an organic electroluminescent element comprising a pair of electrodes composed of an anode and a cathode, a light-emitting layer arranged between the electrodes, and at least one organic layer arranged between the light-emitting layer and the anode, wherein the light-emitting layer contains, for example, a compound (A), and at least one organic layer arranged between the light-emitting layer and the cathode contains, for example, a compound (a-3). | 08-15-2013 |
Wolfgang Ise, Konstanz DE
Patent application number | Description | Published |
---|---|---|
20140120086 | METHOD FOR PREPARATION OF A HIGH CONCENTRATION LIQUID FORMULATION OF AN ANTIBODY - The present invention provides a method for preparation of a high concentration liquid formulation (HCLF) of an antibody or a fragment thereof. The present invention also relates to a method for stabilizing an anti-CD20 antibody or a fragment thereof in a liquid pharmaceutical formulation. Furthermore, the present invention relates to a liquid pharmaceutical formulation of a veltuzumab antibody or a fragment thereof comprising at least 155 mg/mL of a veltuzumab antibody or a fragment thereof. | 05-01-2014 |
20140271636 | FORMULATION OF AN ANTIBODY AND USE THEREOF - The present invention provides a method for preparation of a lyophilized formulation of an anti-CD 20 antibody as well as to a lyophilized formulation of an anti-CD 20 antibody, comprising an anti-CD 20 antibody and having a residual moisture content in the range of 1% to 10%. The present invention also relates to the reconstituted formulation obtained by the method described herein, the use of said antibody formulation as a medicament, the use of the lyophilized formulation for the preparation of a medicament and a method of treating a patient. | 09-18-2014 |